Skip to main content
Skip to sub-navigation
About USAID Our Work Locations Policy Press Business Careers Stripes Graphic USAID Home
USAID: From The American People Maternal and Child Health A collaborative USAID effort protects health of vulnerable Bolivian children - Click to read this story
Health
Overview »
Environmental Health »
Health Systems »
HIV/AIDS »
Infectious Diseases »
Maternal & Child Health »
Nutrition »
Family Planning »
American Schools and Hospitals Abroad »


 
In the Spotlight


Search



Subscribe

Envelope Contact Global Health

Polio Eradication: Future Challenges


Photo of an infant inside a basket in Angola.
Photo by Ellyn W. Ogden, MPH, USAID

During a “mop up” search for unvaccinated children, this infant in Angola was first missed and then found and immunized. Continued vigilance is required to prevent polio from re-emerging in countries certified polio-free while eradication is pursued in the dwindling number of endemic countries.

Future Challenges

The final years of polio eradication have been compared to the last leg of a marathon and the final ascent to Everest’s summit. Political and financial commitment must remain high. Complacency, lack of vigilance, and reduced vaccination coverage can threaten countries with reintroduction of the virus from other countries. Relaxed surveillance will jeopardize “poliofree” certification. Developing sound post-eradication policies aimed at safely stopping vaccination and reducing the threat of inadvertent or deliberate reintroduction of virus are high priorities for the global program. Perhaps the most important challenge is to learn how to use the lessons learned from polio eradication to improve all immunization and disease control activities in developing countries.

Keeping Up With Growing Populations
Until global certification is achieved and it is deemed safe to stop polio immunization, supplying countries with sufficient oral polio vaccine so they can continue to immunize their under-5 populations will remain a challenge. The introduction of monovalent P1 Oral Polio Vaccine into some countries with no remaining P2 or P3 virus may tip the scales in favor of interrupting transmission where the virus is particularly challenging to eradicate.

go to the previous image go to the index page go to the next image





Back to Top ^

Thu, 17 Feb 2005 15:11:49 -0500
Star